Molecular Basis of Triple Negative Breast Cancer and Implications for Therapy
Triple negative breast cancer is an aggressive form of breast cancer with limited treatment options and is without proven targeted therapy. Understanding the molecular basis of triple negative breast cancer is crucial for effective new drug development. Recent genomewide gene expression and DNA sequ...
Saved in:
Main Authors: | Parvin F. Peddi, Matthew J. Ellis, Cynthia Ma |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2012-01-01
|
Series: | International Journal of Breast Cancer |
Online Access: | http://dx.doi.org/10.1155/2012/217185 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Characterization of Triple Negative Breast Cancer
by: Bernardo Enrique Heredia Martínez, et al.
Published: (2020-09-01) -
Clinical Characteristics in Patients with Triple Negative Breast Cancer
by: Janet Yeh, et al.
Published: (2017-01-01) -
Natural products as part of triple negative breast cancer
by: Yozlem Kobakova, et al.
Published: (2025-01-01) -
Endothelial Cells Potentially Participate in the Metastasis of Triple-Negative Breast Cancer
by: Yanfei Ma, et al.
Published: (2022-01-01) -
Molecular effects of clinically relevant chemotherapeutic agents on choline phospholipid metabolism in triple negative breast cancer cells
by: Caitlin M. Tressler, et al.
Published: (2025-03-01)